ОбзорГрафикНовостиTraderScreen

LBBW Discount Zert EVT 22.11.2024/  DE000LB4Q3G8  /

Frankfurt Zert./LBB
08.11.2024  17:15:09 Изменение+0.330 Бид17:29:33 Предложение17:29:33 Базовый актив Цена исполнения Дата истечения Тип опциона
7.730EUR +4.46% -
Величина цены спроса: -		 -
Величина цены предложения: -		 EVOTEC SE INH O.N. - EUR 22.11.2024 Call
GlobeNewswire 14.05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 11.12.2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 07.11.2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 20.08.2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 07.02.2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 07.02.2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 15.02.2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 08.01.2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 14.09.2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 29.11.2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 10.11.2011 Evotec reports nine months results: Upside materialising
GlobeNewswire 03.11.2011 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 27.10.2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 20.10.2011 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 05.10.2011 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 29.09.2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 09.09.2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 05.09.2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 05.09.2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 18.08.2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 11.08.2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 11.08.2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 04.08.2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 07.07.2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 30.06.2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...